HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
501	1230 ARMITAGE JM, KORMOS RL, Fung JJ, STARZL TE THE CLINICAL-TRIAL OF FK-506 AS PRIMARY AND RESCUE IMMUNOSUPPRESSION IN ADULT CARDIAC TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3054-3057	21	53	4	8
502	1344 UEMOTO S, TANAKA K, HONDA K, TOKUNAGA Y, SANO K, et al. EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 FEB; 55 (2): 288-292	13	53	10	19
503	1865 Doyle HR, Marino IR, Morelli F, Doria C, Aldrighetti L, et al. Assessing risk in liver transplantation - Special reference to the significance of a positive cytotoxic crossmatch ANNALS OF SURGERY. 1996 AUG; 224 (2): 168-177	1	53	9	60
504	145 PARK RK, GOLTZ RW, CAREY TB UNUSUAL CUTANEOUS INFECTIONS ASSOCIATED WITH IMMUNOSUPPRESSIVE THERAPY ARCHIVES OF DERMATOLOGY. 1967; 95 (4): 345-&	1	52	1	5
505	749 TOTTERMAN TH, DANERSUND A, NILSSON K, KILLANDER A CYCLOSPORIN-A IS SELECTIVELY CYTO-TOXIC TO HUMAN-LEUKEMIC T-CELLS INVITRO BLOOD. 1982; 59 (5): 1103-1107	1	52	1	33
506	1457 REYES J, ZEEVI A, RAMOS H, Tzakis AG, TODO S, et al. FREQUENT ACHIEVEMENT OF A DRUG-FREE STATE AFTER ORTHOTOPIC LIVER- TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3315-3319	30	52	5	9
507	2408 Qi SJ, Xu DS, Peng JZ, Vu MD, Wu JP, et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey TRANSPLANTATION. 2000 APR 15; 69 (7): 1275-1283	6	52	10	65
508	2531 Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation BONE MARROW TRANSPLANTATION. 2001 JUL; 28 (2): 181-185	3	52	3	18
509	23 MARCHIORO TL, AXTELL HK, LAVIA MF, WADDELL WR, STARZL TE THE ROLE OF ADRENOCORTICAL STEROIDS IN REVERSING ESTABLISHED HOMOGRAFT REJECTION SURGERY. 1964; 55 (3): 412-417	32	51	1	16
510	456 NAJARIAN JS, SIMMONS RL CLINICAL USE OF ANTILYMPHOCYTE GLOBULIN NEW ENGLAND JOURNAL OF MEDICINE. 1971; 285 (3): 158-&	15	51	8	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
511	886 PTACHCINSKI RJ, BURCKART GJ, VENKATARAMANAN R CYCLOSPORINE DRUG INTELLIGENCE & CLINICAL PHARMACY. 1985; 19 (2): 90-100	1	51	17	114
512	1119 STARZL TE, PORTER KA, MAZZAFERRO V, TODO S, Fung JJ, et al. HEPATOTROPHIC EFFECTS OF FK506 IN DOGS TRANSPLANTATION. 1991 JAN; 51 (1): 67-70	10	51	3	21
513	1386 BACKMAN L, GIBBS J, LEVY M, MCMILLAN R, HOLMAN M, et al. CAUSES OF LATE GRAFT LOSS AFTER LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 MAY; 55 (5): 1078-1082	2	51	4	16
514	1477 CARTON EG, PLEVAK DJ, KRANNER PW, RETTKE SR, GEIGER HJ, et al. PERIOPERATIVE CARE OF THE LIVER-TRANSPLANT PATIENT .2. ANESTHESIA AND ANALGESIA. 1994 FEB; 78 (2): 382-399	1	51	3	151
515	2285 Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, et al. In vitro evidence for the presence of hematopoietic stem cells in the adult human liver HEPATOLOGY. 1999 APR; 29 (4): 1193-1198	4	51	4	23
516	2288 Tang S, Zhou WD, Sheerin NS, Vaughan RW, Sacks SH Contribution of renal secreted complement C3 to the circulating pool in humans JOURNAL OF IMMUNOLOGY. 1999 APR 1; 162 (7): 4336-4341	0	51	2	35
517	2864 Reyes J, Mazariegos GV, Abu-Elmagd K, Macedo C, Bond GJ, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin((R))) AMERICAN JOURNAL OF TRANSPLANTATION. 2005 JUN; 5 (6): 1430-1436	12	51	9	30
518	2944 Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy AMERICAN JOURNAL OF TRANSPLANTATION. 2006 OCT; 6 (10): 2409-2417	5	51	6	25
519	39 SCRIBNER BH, FERGUS EB, BOEN ST, THOMAS ED SOME THERAPEUTIC APPROACHES TO CHRONIC RENAL INSUFFICIENCY ANNUAL REVIEW OF MEDICINE. 1965; 16: 285-&	2	50	1	79
520	520 BELZER FO, SCHWEIZE.RT, KOUNTZ SL MANAGEMENT OF MULTIPLE VESSELS IN RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1972; 4 (4): 639-644	7	50	1	1
#	Date / Author / Journal	LCS	GCS	LCR	CR
521	602 MCGRATH BP, IBELS LS, RAIK E, HARGRAVE M, MAHONY JF, et al. ERYTHROID TOXICITY OF AZATHIOPRINE - MACROCYTOSIS AND SELECTIVE MARROW HYPOPLASIA QUARTERLY JOURNAL OF MEDICINE. 1975; 44 (173): 57-63	0	50	2	17
522	1123 MACLEOD AM, THOMSON AW FK-506 - AN IMMUNOSUPPRESSANT FOR THE 1990S LANCET. 1991 JAN 5; 337 (8732): 25-27	7	50	6	49
523	1148 MCCAULEY J, TAKAYA S, Fung JJ, Tzakis AG, ABUELMAGD K, et al. THE QUESTION OF FK506 NEPHROTOXICITY AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 1444-1447	21	50	5	19
524	1263 VIERLING JM IMMUNOLOGICAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION SEMINARS IN LIVER DISEASE. 1992 FEB; 12 (1): 16-27	5	50	3	83
525	2279 Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, et al. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients. TRANSPLANTATION. 1999 MAR 15; 67 (5): 707-712	3	50	2	12
526	2428 Rovira P, Mascarell L, Truffa-Bachi P The impact of immunosuppressive drugs on the analysis of T-cell activation CURRENT MEDICINAL CHEMISTRY. 2000 JUL; 7 (7): 673-692	1	50	6	133
527	2725 Ng IOL, Chan KL, Shek WH, Lee JMF, Fong DYT, et al. High frequency of chimerism in transplanted livers HEPATOLOGY. 2003 OCT; 38 (4): 989-998	4	50	7	36
528	2778 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, et al. Recurrent hepatitis C in liver allografts - Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2004 MAY; 28 (5): 658-669	3	50	6	42
529	589 SCIARRA JJ, TOLEDOPEREYRA LH, BENDEL RP, SIMMONS RL PREGNANCY FOLLOWING RENAL-TRANSPLANTATION AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 1975; 123 (4): 411-425	2	49	2	34
530	680 STARZL TE, WEIL R, KOEP LJ, MCCALMON RT, TERASAKI PI, et al. THORACIC-DUCT FISTULA AND RENAL-TRANSPLANTATION ANNALS OF SURGERY. 1979; 190 (4): 474-486	9	49	7	55
#	Date / Author / Journal	LCS	GCS	LCR	CR
531	709 LIN SN, JESSUP K, FLOYD M, WANG TPF, VANBUREN CT, et al. QUANTITATION OF PLASMA AZATHIOPRINE AND 6-MERCAPTOPURINE LEVELS IN RENAL-TRANSPLANT PATIENTS TRANSPLANTATION. 1980; 29 (4): 290-294	2	49	3	19
532	762 STARZL TE, MALATACK JJ, GARTNER JC, ROSENTHAL JT LIVER AND KIDNEY-TRANSPLANTATION IN CHILDREN RECEIVING CYCLOSPORIN-A AND STEROIDS JOURNAL OF PEDIATRICS. 1982; 100 (5): 681-686	12	49	14	28
533	918 FRISKOPP J, KLINTMALM G GINGIVAL ENLARGEMENT - A COMPARISON BETWEEN CYCLOSPORINE AND AZATHIOPRINE TREATED RENAL-ALLOGRAFT RECIPIENTS SWEDISH DENTAL JOURNAL. 1986; 10 (3): 85-92	5	49	3	14
534	1001 STRATTA RJ, DALESSANDRO AM, ARMBRUST MJ, PIRSCH JD, SOLLINGER HW, et al. SEQUENTIAL ANTILYMPHOCYTE GLOBULIN CYCLOSPORINE IMMUNOSUPPRESSION IN CADAVERIC RENAL-TRANSPLANTATION - EFFECT OF DURATION OF ALG THERAPY TRANSPLANTATION. 1989 JAN; 47 (1): 96-102	7	49	9	33
535	2443 Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation TRANSPLANTATION. 2000 AUG 27; 70 (4): 617-625	6	49	17	37
536	2497 Ringe B, Braun F, Schutz E, Fuzesi L, Lorf T, et al. A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil TRANSPLANTATION. 2001 FEB 27; 71 (4): 508-515	3	49	6	39
537	373 GONZALEZ LL, MARTIN L, WEST CD, SPOTZER R, MCENERY P RENAL HOMOTRANSPLANTATION IN CHILDREN ARCHIVES OF SURGERY. 1970; 101 (2): 232-&	6	48	3	15
538	397 REED WP, LUCAS ZJ, COHN R ALTERNATE-DAY PREDNISONE THERAPY AFTER RENAL TRANSPLANTATION LANCET. 1970; 1 (7650): 747-&	4	48	3	7
539	702 STUART FP, RECKARD CR, KETEL BL, SCHULAK JA EFFECT OF SPLENECTOMY ON 1ST CADAVER KIDNEY-TRANSPLANTS ANNALS OF SURGERY. 1980; 192 (4): 553-561	6	48	5	33
540	800 NOVICK AC, BRAUN WE, STEINMULLER D, BUSZTA C, GREENSTREET R, et al. A CONTROLLED RANDOMIZED DOUBLE-BLIND-STUDY OF ANTILYMPHOBLAST GLOBULIN IN CADAVER RENAL-TRANSPLANTATION TRANSPLANTATION. 1983; 35 (2): 175-179	13	48	3	13
#	Date / Author / Journal	LCS	GCS	LCR	CR
541	807 IWATSUKI S, STARZL TE, SHAW BW, YANG SL, ZITELLI BJ, et al. LONG-TERM USE OF CYCLOSPORINE IN LIVER RECIPIENTS - REDUCTION OF DOSAGES IN THE 1ST YEAR TO AVOID NEPHROTOXICITY TRANSPLANTATION. 1983; 36 (6): 641-643	7	48	3	4
542	1136 JAIN AB, FUNG JJ, TODO S, ALESSIANI M, TAKAYA S, et al. INCIDENCE AND TREATMENT OF REJECTION EPISODES IN PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION UNDER FK506 TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 928-930	18	48	6	12
543	1598 ISHIOKA M, OHNO S, NAKAMURA S, ISOBE K, WATANABE N, et al. FK506 TREATMENT OF NONINFECTIOUS UVEITIS AMERICAN JOURNAL OF OPHTHALMOLOGY. 1994 DEC 15; 118 (6): 723-729	2	48	2	19
544	2985 Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, et al. The liver: A special case in transplantation tolerance SEMINARS IN LIVER DISEASE. 2007 MAY; 27 (2): 194-213	12	48	50	200
545	959 WYSOCKI GP, DALEY TD HYPERTRICHOSIS IN PATIENTS RECEIVING CYCLOSPORINE THERAPY CLINICAL AND EXPERIMENTAL DERMATOLOGY. 1987 MAY; 12 (3): 191-196	2	47	3	11
546	1061 VONKIPARSKI A, FREI D, UHLSCHMID G, LARGIADER F, BINSWANGER U POSTTRANSPLANT DIABETES-MELLITUS IN RENAL-ALLOGRAFT RECIPIENTS - A MATCHED-PAIR CONTROL STUDY NEPHROLOGY DIALYSIS TRANSPLANTATION. 1990 MAR; 5 (3): 220-225	6	47	3	19
547	1584 WINKLER M, RINGE B, BAUMANN J, LOSS M, WONIGEIT K, et al. PLASMA VS WHOLE-BLOOD FOR THERAPEUTIC DRUG-MONITORING OF PATIENTS RECEIVING FK-506 FOR IMMUNOSUPPRESSION CLINICAL CHEMISTRY. 1994 DEC; 40 (12): 2247-2253	6	47	11	25
548	1804 Starzl TE, Murase N, Thomson A, Demetris AJ Liver transplants contribute to their own success NATURE MEDICINE. 1996 FEB; 2 (2): 163-165	21	47	13	22
549	2138 Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, et al. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients TRANSPLANTATION. 1998 APR 15; 65 (7): 956-965	23	47	9	36
550	2334 Lu L, Li W, Zhong CP, Qian SG, Fung JJ, et al. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb TRANSPLANTATION. 1999 SEP 27; 68 (6): 747-757	16	47	23	58
#	Date / Author / Journal	LCS	GCS	LCR	CR
551	2785 Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu DL DNA fusion gene vaccines against cancer: from the laboratory to the clinic IMMUNOLOGICAL REVIEWS. 2004 JUN; 199 (1): 156-180	0	47	2	176
552	495 ANDERSON EE, GLENN JF, STICKEL DL, SEIGLER HF UROLOGIC COMPLICATIONS IN RENAL-TRANSPLANTATION JOURNAL OF UROLOGY. 1972; 107 (2): 187-&	2	46	1	5
553	837 OTA B, BRADLEY M SIDE-EFFECTS OF CYCLOSPORINE IN 100 RENAL-ALLOGRAFT RECIPIENTS TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 3150-3156	5	46	4	25
554	1369 TAKEGUCHI N, ICHIMURA K, KOIKE M, MATSUI W, KASHIWAGURA T, et al. INHIBITION OF THE MULTIDRUG EFFLUX PUMP IN ISOLATED HEPATOCYTE COUPLETS BY IMMUNOSUPPRESSANTS FK506 AND CYCLOSPORINE TRANSPLANTATION. 1993 MAR; 55 (3): 646-650	0	46	2	30
555	1446 FABIAN MC, LAKEY JRT, RAJOTTE RV, KNETEMAN NM THE EFFICACY AND TOXICITY OF RAPAMYCIN IN MURINE ISLET TRANSPLANTATION - IN-VITRO AND IN-VIVO STUDIES TRANSPLANTATION. 1993 NOV; 56 (5): 1137-1142	2	46	6	45
556	1467 DUNCAN JI DIFFERENTIAL INHIBITION OF CUTANEOUS T-CELL-MEDIATED REACTIONS AND EPIDERMAL-CELL PROLIFERATION BY CYCLOSPORINE-A, FK-506, AND RAPAMYCIN JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1994 JAN; 102 (1): 84-88	1	46	5	38
557	1488 HIGH KP, JOINER KA, HANDSCHUMACHER RE ISOLATION, CDNA SEQUENCES, AND BIOCHEMICAL-CHARACTERIZATION OF THE MAJOR CYCLOSPORINE-BINDING PROTEINS OF TOXOPLASMA-GONDII JOURNAL OF BIOLOGICAL CHEMISTRY. 1994 MAR 25; 269 (12): 9105-9112	0	46	3	69
558	1626 GORCZYNSKI RM REGULATION OF IFN-GAMMA AND IL-10 SYNTHESIS IN-VIVO, AS WELL AS CONTINUOUS ANTIGEN EXPOSURE, IS ASSOCIATED WITH TOLERANCE TO MURINE SKIN ALLOGRAFTS CELLULAR IMMUNOLOGY. 1995 FEB; 160 (2): 224-231	8	46	1	27
559	1663 THOMSON AW, LU L, SUBBOTIN VM, LI YP, QIAN SG, et al. IN-VITRO PROPAGATION AND HOMING OF LIVER-DERIVED DENDRITIC CELL PROGENITORS TO LYMPHOID-TISSUES OF ALLOGENEIC RECIPIENTS - IMPLICATIONS FOR THE ESTABLISHMENT AND MAINTENANCE OF DONOR CELL CHIMERISM FOLLOWING LIVER-TRANSPLANTATION TRANSPLANTATION. 1995 FEB 27; 59 (4): 544-551	32	46	8	31
560	1752 STARZL TE, DONNER A, ELIASZIW M, STITT L, MEIER P, et al. RANDOMIZED TRIALOMANIA - THE MULTICENTER LIVER-TRANSPLANT TRIALS OF TACROLIMUS LANCET. 1995 NOV 18; 346 (8986): 1346-1350	22	46	14	29
#	Date / Author / Journal	LCS	GCS	LCR	CR
561	1908 GarciaMorales R, Esquenazi V, Zucker K, Gomez CI, Fuller L, et al. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry TRANSPLANTATION. 1996 OCT 27; 62 (8): 1149-1160	26	46	5	24
562	2122 Paradis I Bronchiolitis obliterans: Pathogenesis, prevention, and management AMERICAN JOURNAL OF THE MEDICAL SCIENCES. 1998 MAR; 315 (3): 161-178	1	46	12	165
563	2368 Gorantla VS, Barker JH, Jones JW, Prabhune K, Maldonado C, et al. Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies MICROSURGERY. 2000; 20 (8): 420-429	5	46	8	61
564	2426 Morelli AE, O'Connell PJ, Khanna A, Logar AJ, Lu L, et al. Preferential induction of Th1 responses by functionally mature hepatic (CD8 alpha(-) and CD8 alpha(+)) dendritic cells - Association with conversion from liver transplant tolerance to acute rejection TRANSPLANTATION. 2000 JUN 27; 69 (12): 2647-2657	8	46	22	45
565	2776 Taylor AL, Gibbs P, Bradley JA Acute graft versus host disease following liver transplantation: The enemy within AMERICAN JOURNAL OF TRANSPLANTATION. 2004 APR; 4 (4): 466-474	9	46	11	74
566	221 MANDEL MA, ASOFSKY R EFFECTS OF HETEROLOGOUS ANTI-THYMOCYTE SERA IN MICE .I. USE OF A GRAFT-VS-HOST ASSAY AS A MEASURE OF HOMOGRAFT REACTIVITY JOURNAL OF IMMUNOLOGY. 1968; 100 (6): 1319-&	5	45	1	11
567	272 SELL S ANTILYMPHOCYTIC ANTIBODY - EFFECTS IN EXPERIMENTAL ANIMALS AND PROBLEMS IN HUMAN USE ANNALS OF INTERNAL MEDICINE. 1969; 71 (1): 177-&	3	45	21	156
568	681 MEYERS WC, HARRIS N, STEIN S, BROOKS M, JONES RS, et al. ALIMENTARY-TRACT COMPLICATIONS AFTER RENAL-TRANSPLANTATION ANNALS OF SURGERY. 1979; 190 (4): 535-542	1	45	4	36
569	1006 STARZL TE, TODO S, Tzakis AG, GORDON RD, MAKOWKA L, et al. LIVER-TRANSPLANTATION - AN UNFINISHED PRODUCT TRANSPLANTATION PROCEEDINGS. 1989 FEB; 21 (1): 2197-2197	7	45	5	15
570	1016 BIRD G, FRIEND P, DONALDSON P, OGRADY J, PORTMANN B, et al. HYPERACUTE REJECTION IN LIVER-TRANSPLANTATION - A CASE-REPORT TRANSPLANTATION PROCEEDINGS. 1989 AUG; 21 (4): 3742-3744	9	45	2	19
#	Date / Author / Journal	LCS	GCS	LCR	CR
571	1701 KANAMARU A, TAKEMOTO Y, KAKISHITA E, DOHY H, KODERA Y, et al. FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND/OR OTHER IMMUNOSUPPRESSANTS BONE MARROW TRANSPLANTATION. 1995 JUN; 15 (6): 885-889	3	45	7	16
572	1957 Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, et al. Positive and negative MHC class I recognition by rat NK cells IMMUNOLOGICAL REVIEWS. 1997 FEB; 155: 91-104	1	45	1	72
573	2111 Bumgardner GL, Li JS, Heininger M, Ferguson RM, Orosz CG In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model TRANSPLANTATION. 1998 JAN 15; 65 (1): 47-52	7	45	5	33
574	2199 Ehl S, Aichele P, Ramseier H, Barchet W, Hombach J, et al. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection NATURE MEDICINE. 1998 SEP; 4 (9): 1015-1019	17	45	5	45
575	2559 Wong SHY Therapeutic drug monitoring for immunosuppressants CLINICA CHIMICA ACTA. 2001 NOV; 313 (1-2): 241-253	0	45	10	93
576	2680 Creput C, Durrbach A, Samuel D, Eschwege P, Amor M, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation AMERICAN JOURNAL OF TRANSPLANTATION. 2003 MAR; 3 (3): 348-356	6	45	5	28
577	2847 Fung JJ, Kelly D, Kadry Z, Patel-Tom K, Eghtesad B Immunosuppression in liver transplantation beyond calcineurin inhibitors LIVER TRANSPLANTATION. 2005 MAR; 11 (3): 267-280	1	45	8	100
578	3036 Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-Regulatory cells in liver transplant tolerance TRANSPLANTATION. 2008 FEB 15; 85 (3): 369-377	7	45	11	50
579	109 GUNNELLS JC, STICKEL DL, ROBINSON RR EPISODIC HYPERTENSION ASSOCIATED WITH POSITIVE RENIN ASSAYS AFTER RENAL TRANSPLANTATION NEW ENGLAND JOURNAL OF MEDICINE. 1966; 274 (10): 543-&	0	44	2	12
580	400 MCPHAUL JJ, DIXON FJ, BRETTSCH.L, STARZL TE IMMUNOFLUORESCENT EXAMINATION OF BIOPSIES FROM LONG-TERM RENAL ALLOGRAFTS NEW ENGLAND JOURNAL OF MEDICINE. 1970; 282 (8): 412-&	8	44	7	23
#	Date / Author / Journal	LCS	GCS	LCR	CR
581	689 NOVICK AC, MAGNUSSON M, BRAUN WE MULTIPLE-ARTERY RENAL-TRANSPLANTATION - EMPHASIS ON EXTRACORPOREAL METHODS OF DONOR ARTERIAL RECONSTRUCTION JOURNAL OF UROLOGY. 1979; 122 (6): 731-735	1	44	3	9
582	795 IWATSUKI S, SHAW BW, STARZL TE CURRENT STATUS OF HEPATIC TRANSPLANTATION SEMINARS IN LIVER DISEASE. 1983; 3 (3): 173-180	0	44	10	25
583	891 CONLEY SB, FLECHNER SM, ROSE G, VANBUREN CT, BREWER E, et al. USE OF CYCLOSPORINE IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS JOURNAL OF PEDIATRICS. 1985; 106 (1): 45-49	5	44	5	25
584	906 STARZL TE, IWATSUKI S, SHAW BW, GORDON RD, ESQUIVEL C, et al. FACTORS IN THE DEVELOPMENT OF LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1985; 17: 107-119	0	44	17	61
585	1002 ROZA AM, PERLOFF LJ, NAJI A, GROSSMAN RA, BARKER CF LIVING-RELATED DONORS WITH BILATERAL MULTIPLE RENAL-ARTERIES - A 20-YEAR EXPERIENCE TRANSPLANTATION. 1989 FEB; 47 (2): 397-399	0	44	1	3
586	1239 MCCAULEY J, FUNG JJ, TODO S, JAIN A, DEBALLI P, et al. CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506 TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3143-3145	16	44	5	8
587	1377 THOMSON AW, CARROLL PB, MCCAULEY J, WOO J, ABUELMAGD K, et al. FK-506 - A NOVEL IMMUNOSUPPRESSANT FOR TREATMENT OF AUTOIMMUNE-DISEASE - RATIONALE AND PRELIMINARY CLINICAL-EXPERIENCE AT THE UNIVERSITY-OF- PITTSBURGH SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 1993 APR; 14 (4): 323-344	9	44	7	56
588	1393 GIANELLO P, FISHBEIN JM, SACHS DH TOLERANCE TO PRIMARILY VASCULARIZED ALLOGRAFTS IN MINIATURE SWINE IMMUNOLOGICAL REVIEWS. 1993 JUN; 133: 19-44	4	44	2	91
589	1653 SHAPIRO R, JORDAN ML, SCANTLEBURY VP, VIVAS C, FUNG JJ, et al. A PROSPECTIVE, RANDOMIZED TRIAL OF FK-506 PREDNISONE VS FK-506 AZATHIOPRINE/PREDNISONE IN RENAL-TRANSPLANT PATIENTS TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 814-817	7	44	12	26
590	1710 STEINMAN R, HOFFMAN L, POPE M MATURATION AND MIGRATION OF CUTANEOUS DENDRITIC CELLS JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1995 JUL; 105 (1): S2-S7	0	44	1	89
#	Date / Author / Journal	LCS	GCS	LCR	CR
591	1862 Mayumi H, Umesue M, Nomoto K Cyclophosphamide-induced immunological tolerance: An overview IMMUNOBIOLOGY. 1996 JUL; 195 (2): 129-139	2	44	5	73
592	1950 Tu YZ, Arima T, Flye MW Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation TRANSPLANTATION. 1997 JAN 27; 63 (2): 177-181	20	44	4	46
593	2753 Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, et al. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen- activated protein kinases and NF-kappa B BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2004 JAN 2; 313 (1): 148-155	2	44	2	49
594	429 TORISU M, YOKOYAMA T, AMEMIYA H, KOHLER PF, SCHROTER G, et al. IMMUNOSUPPRESSION, LIVER INJURY, AND HEPATITIS IN RENAL, HEPATIC, AND CARDIAC HOMOGRAFT RECIPIENTS - WITH PARTICULAR REFERENCE TO AUSTRALIA ANTIGEN ANNALS OF SURGERY. 1971; 174 (4): 620-&	3	43	4	78
595	679 GUICE K, RATTAZZI LC, MARCHIORO TL COLON PERFORATION IN RENAL-TRANSPLANT PATIENTS AMERICAN JOURNAL OF SURGERY. 1979; 138 (1): 43-48	0	43	5	28
596	747 STROM TB THE IMPROVING UTILITY OF RENAL-TRANSPLANTATION IN THE MANAGEMENT OF END-STAGE RENAL-DISEASE AMERICAN JOURNAL OF MEDICINE. 1982; 73 (1): 105-124	3	43	13	148
597	848 YATSCOFF RW, RUSH DN, JEFFERY JR EFFECTS OF SAMPLE PREPARATION ON CONCENTRATIONS OF CYCLOSPORIN-A MEASURED IN PLASMA CLINICAL CHEMISTRY. 1984; 30 (11): 1812-1814	2	43	1	9
598	913 MAKOWKA L, LOPATIN W, GILAS T, FALK J, PHILLIPS MJ, et al. PREVENTION OF CYCLOSPORINE (CYA) NEPHROTOXICITY BY SYNTHETIC PROSTAGLANDINS CLINICAL NEPHROLOGY. 1986; 25: S89-S94	1	43	3	10
599	1015 FRIEND PJ, HALE G, WALDMANN H, GORE S, THIRU S, et al. CAMPATH-1M - PROPHYLACTIC USE AFTER KIDNEY-TRANSPLANTATION - A RANDOMIZED CONTROLLED CLINICAL-TRIAL TRANSPLANTATION. 1989 AUG; 48 (2): 248-253	4	43	3	28
600	1028 MONAGHAN RL, TKACZ JS BIOACTIVE MICROBIAL PRODUCTS - FOCUS UPON MECHANISM OF ACTION ANNUAL REVIEW OF MICROBIOLOGY. 1990; 44: 271-301	0	43	1	260

Date / Author / Journal

LCS

GCS

LCR

501

1230 ARMITAGE JM, KORMOS RL, Fung JJ, STARZL TE

THE CLINICAL-TRIAL OF FK-506 AS PRIMARY AND RESCUE IMMUNOSUPPRESSION IN ADULT CARDIAC TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3054-3057

502

1344 UEMOTO S, TANAKA K, HONDA K, TOKUNAGA Y, SANO K, et al.

EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 FEB; 55 (2): 288-292

503

1865 Doyle HR, Marino IR, Morelli F, Doria C, Aldrighetti L, et al.

Assessing risk in liver transplantation - Special reference to the significance of a positive cytotoxic crossmatch

ANNALS OF SURGERY. 1996 AUG; 224 (2): 168-177

504

145 PARK RK, GOLTZ RW, CAREY TB

UNUSUAL CUTANEOUS INFECTIONS ASSOCIATED WITH IMMUNOSUPPRESSIVE THERAPY

ARCHIVES OF DERMATOLOGY. 1967; 95 (4): 345-&

505

749 TOTTERMAN TH, DANERSUND A, NILSSON K, KILLANDER A

CYCLOSPORIN-A IS SELECTIVELY CYTO-TOXIC TO HUMAN-LEUKEMIC T-CELLS INVITRO

BLOOD. 1982; 59 (5): 1103-1107

506

1457 REYES J, ZEEVI A, RAMOS H, Tzakis AG, TODO S, et al.

FREQUENT ACHIEVEMENT OF A DRUG-FREE STATE AFTER ORTHOTOPIC LIVER- TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 DEC; 25 (6): 3315-3319

507

2408 Qi SJ, Xu DS, Peng JZ, Vu MD, Wu JP, et al.

Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey

TRANSPLANTATION. 2000 APR 15; 69 (7): 1275-1283

508

2531 Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, et al.

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

BONE MARROW TRANSPLANTATION. 2001 JUL; 28 (2): 181-185

509

23 MARCHIORO TL, AXTELL HK, LAVIA MF, WADDELL WR, STARZL TE

THE ROLE OF ADRENOCORTICAL STEROIDS IN REVERSING ESTABLISHED HOMOGRAFT REJECTION

SURGERY. 1964; 55 (3): 412-417

510

456 NAJARIAN JS, SIMMONS RL

CLINICAL USE OF ANTILYMPHOCYTE GLOBULIN

NEW ENGLAND JOURNAL OF MEDICINE. 1971; 285 (3): 158-&

Date / Author / Journal

LCS

GCS

LCR

511

886 PTACHCINSKI RJ, BURCKART GJ, VENKATARAMANAN R

CYCLOSPORINE

DRUG INTELLIGENCE & CLINICAL PHARMACY. 1985; 19 (2): 90-100

114

512

1119 STARZL TE, PORTER KA, MAZZAFERRO V, TODO S, Fung JJ, et al.

HEPATOTROPHIC EFFECTS OF FK506 IN DOGS

TRANSPLANTATION. 1991 JAN; 51 (1): 67-70

513

1386 BACKMAN L, GIBBS J, LEVY M, MCMILLAN R, HOLMAN M, et al.

CAUSES OF LATE GRAFT LOSS AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 MAY; 55 (5): 1078-1082

514

1477 CARTON EG, PLEVAK DJ, KRANNER PW, RETTKE SR, GEIGER HJ, et al.

PERIOPERATIVE CARE OF THE LIVER-TRANSPLANT PATIENT .2.

ANESTHESIA AND ANALGESIA. 1994 FEB; 78 (2): 382-399

151

515

2285 Crosbie OM, Reynolds M, McEntee G, Traynor O, Hegarty JE, et al.

In vitro evidence for the presence of hematopoietic stem cells in the adult human liver

HEPATOLOGY. 1999 APR; 29 (4): 1193-1198

516

2288 Tang S, Zhou WD, Sheerin NS, Vaughan RW, Sacks SH

Contribution of renal secreted complement C3 to the circulating pool in humans

JOURNAL OF IMMUNOLOGY. 1999 APR 1; 162 (7): 4336-4341

517

2864 Reyes J, Mazariegos GV, Abu-Elmagd K, Macedo C, Bond GJ, et al.

Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin((R)))

AMERICAN JOURNAL OF TRANSPLANTATION. 2005 JUN; 5 (6): 1430-1436

518

2944 Tan HP, Kaczorowski DJ, Basu A, Unruh M, McCauley J, et al.

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy

AMERICAN JOURNAL OF TRANSPLANTATION. 2006 OCT; 6 (10): 2409-2417

519

39 SCRIBNER BH, FERGUS EB, BOEN ST, THOMAS ED

SOME THERAPEUTIC APPROACHES TO CHRONIC RENAL INSUFFICIENCY

ANNUAL REVIEW OF MEDICINE. 1965; 16: 285-&

520

520 BELZER FO, SCHWEIZE.RT, KOUNTZ SL

MANAGEMENT OF MULTIPLE VESSELS IN RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1972; 4 (4): 639-644

Date / Author / Journal

LCS

GCS

LCR

521

602 MCGRATH BP, IBELS LS, RAIK E, HARGRAVE M, MAHONY JF, et al.

ERYTHROID TOXICITY OF AZATHIOPRINE - MACROCYTOSIS AND SELECTIVE MARROW HYPOPLASIA

QUARTERLY JOURNAL OF MEDICINE. 1975; 44 (173): 57-63

522

1123 MACLEOD AM, THOMSON AW

FK-506 - AN IMMUNOSUPPRESSANT FOR THE 1990S

LANCET. 1991 JAN 5; 337 (8732): 25-27

523

1148 MCCAULEY J, TAKAYA S, Fung JJ, Tzakis AG, ABUELMAGD K, et al.

THE QUESTION OF FK506 NEPHROTOXICITY AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 1444-1447

524

1263 VIERLING JM

IMMUNOLOGICAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION

SEMINARS IN LIVER DISEASE. 1992 FEB; 12 (1): 16-27

525

2279 Hebert MF, Ascher NL, Lake JR, Emond J, Nikolai B, et al.

Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.

TRANSPLANTATION. 1999 MAR 15; 67 (5): 707-712

526

2428 Rovira P, Mascarell L, Truffa-Bachi P

The impact of immunosuppressive drugs on the analysis of T-cell activation

CURRENT MEDICINAL CHEMISTRY. 2000 JUL; 7 (7): 673-692

133

527

2725 Ng IOL, Chan KL, Shek WH, Lee JMF, Fong DYT, et al.

High frequency of chimerism in transplanted livers

HEPATOLOGY. 2003 OCT; 38 (4): 989-998

528

2778 Demetris AJ, Eghtesad B, Marcos A, Ruppert K, Nalesnik MA, et al.

Recurrent hepatitis C in liver allografts - Prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis

AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2004 MAY; 28 (5): 658-669

529

589 SCIARRA JJ, TOLEDOPEREYRA LH, BENDEL RP, SIMMONS RL

PREGNANCY FOLLOWING RENAL-TRANSPLANTATION

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 1975; 123 (4): 411-425

530

680 STARZL TE, WEIL R, KOEP LJ, MCCALMON RT, TERASAKI PI, et al.

THORACIC-DUCT FISTULA AND RENAL-TRANSPLANTATION

ANNALS OF SURGERY. 1979; 190 (4): 474-486

Date / Author / Journal

LCS

GCS

LCR

531

709 LIN SN, JESSUP K, FLOYD M, WANG TPF, VANBUREN CT, et al.

QUANTITATION OF PLASMA AZATHIOPRINE AND 6-MERCAPTOPURINE LEVELS IN RENAL-TRANSPLANT PATIENTS

TRANSPLANTATION. 1980; 29 (4): 290-294

532

762 STARZL TE, MALATACK JJ, GARTNER JC, ROSENTHAL JT

LIVER AND KIDNEY-TRANSPLANTATION IN CHILDREN RECEIVING CYCLOSPORIN-A AND STEROIDS

JOURNAL OF PEDIATRICS. 1982; 100 (5): 681-686

533

918 FRISKOPP J, KLINTMALM G

GINGIVAL ENLARGEMENT - A COMPARISON BETWEEN CYCLOSPORINE AND AZATHIOPRINE TREATED RENAL-ALLOGRAFT RECIPIENTS

SWEDISH DENTAL JOURNAL. 1986; 10 (3): 85-92

534

1001 STRATTA RJ, DALESSANDRO AM, ARMBRUST MJ, PIRSCH JD, SOLLINGER HW, et al.

SEQUENTIAL ANTILYMPHOCYTE GLOBULIN CYCLOSPORINE IMMUNOSUPPRESSION IN CADAVERIC RENAL-TRANSPLANTATION - EFFECT OF DURATION OF ALG THERAPY

TRANSPLANTATION. 1989 JAN; 47 (1): 96-102

535

2443 Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, et al.

Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation

TRANSPLANTATION. 2000 AUG 27; 70 (4): 617-625

536

2497 Ringe B, Braun F, Schutz E, Fuzesi L, Lorf T, et al.

A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil

TRANSPLANTATION. 2001 FEB 27; 71 (4): 508-515

537

373 GONZALEZ LL, MARTIN L, WEST CD, SPOTZER R, MCENERY P

RENAL HOMOTRANSPLANTATION IN CHILDREN

ARCHIVES OF SURGERY. 1970; 101 (2): 232-&

538

397 REED WP, LUCAS ZJ, COHN R

ALTERNATE-DAY PREDNISONE THERAPY AFTER RENAL TRANSPLANTATION

LANCET. 1970; 1 (7650): 747-&

539

702 STUART FP, RECKARD CR, KETEL BL, SCHULAK JA

EFFECT OF SPLENECTOMY ON 1ST CADAVER KIDNEY-TRANSPLANTS

ANNALS OF SURGERY. 1980; 192 (4): 553-561

540

800 NOVICK AC, BRAUN WE, STEINMULLER D, BUSZTA C, GREENSTREET R, et al.

A CONTROLLED RANDOMIZED DOUBLE-BLIND-STUDY OF ANTILYMPHOBLAST GLOBULIN IN CADAVER RENAL-TRANSPLANTATION

TRANSPLANTATION. 1983; 35 (2): 175-179

Date / Author / Journal

LCS

GCS

LCR

541

807 IWATSUKI S, STARZL TE, SHAW BW, YANG SL, ZITELLI BJ, et al.

LONG-TERM USE OF CYCLOSPORINE IN LIVER RECIPIENTS - REDUCTION OF DOSAGES IN THE 1ST YEAR TO AVOID NEPHROTOXICITY

TRANSPLANTATION. 1983; 36 (6): 641-643

542

1136 JAIN AB, FUNG JJ, TODO S, ALESSIANI M, TAKAYA S, et al.

INCIDENCE AND TREATMENT OF REJECTION EPISODES IN PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION UNDER FK506

TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 928-930

543

1598 ISHIOKA M, OHNO S, NAKAMURA S, ISOBE K, WATANABE N, et al.

FK506 TREATMENT OF NONINFECTIOUS UVEITIS

AMERICAN JOURNAL OF OPHTHALMOLOGY. 1994 DEC 15; 118 (6): 723-729

544

2985 Benseler V, McCaughan GW, Schlitt HJ, Bishop GA, Bowen DG, et al.

The liver: A special case in transplantation tolerance

SEMINARS IN LIVER DISEASE. 2007 MAY; 27 (2): 194-213

200

545

959 WYSOCKI GP, DALEY TD

HYPERTRICHOSIS IN PATIENTS RECEIVING CYCLOSPORINE THERAPY

CLINICAL AND EXPERIMENTAL DERMATOLOGY. 1987 MAY; 12 (3): 191-196

546

1061 VONKIPARSKI A, FREI D, UHLSCHMID G, LARGIADER F, BINSWANGER U

POSTTRANSPLANT DIABETES-MELLITUS IN RENAL-ALLOGRAFT RECIPIENTS - A MATCHED-PAIR CONTROL STUDY

NEPHROLOGY DIALYSIS TRANSPLANTATION. 1990 MAR; 5 (3): 220-225

547

1584 WINKLER M, RINGE B, BAUMANN J, LOSS M, WONIGEIT K, et al.

PLASMA VS WHOLE-BLOOD FOR THERAPEUTIC DRUG-MONITORING OF PATIENTS RECEIVING FK-506 FOR IMMUNOSUPPRESSION

CLINICAL CHEMISTRY. 1994 DEC; 40 (12): 2247-2253

548

1804 Starzl TE, Murase N, Thomson A, Demetris AJ

Liver transplants contribute to their own success

NATURE MEDICINE. 1996 FEB; 2 (2): 163-165

549

2138 Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, et al.

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients

TRANSPLANTATION. 1998 APR 15; 65 (7): 956-965

550

2334 Lu L, Li W, Zhong CP, Qian SG, Fung JJ, et al.

Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb

TRANSPLANTATION. 1999 SEP 27; 68 (6): 747-757

Date / Author / Journal

LCS

GCS

LCR

551

2785 Stevenson FK, Rice J, Ottensmeier CH, Thirdborough SM, Zhu DL

DNA fusion gene vaccines against cancer: from the laboratory to the clinic

IMMUNOLOGICAL REVIEWS. 2004 JUN; 199 (1): 156-180

176

552

495 ANDERSON EE, GLENN JF, STICKEL DL, SEIGLER HF

UROLOGIC COMPLICATIONS IN RENAL-TRANSPLANTATION

JOURNAL OF UROLOGY. 1972; 107 (2): 187-&

553

837 OTA B, BRADLEY M

SIDE-EFFECTS OF CYCLOSPORINE IN 100 RENAL-ALLOGRAFT RECIPIENTS

TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 3150-3156

554

1369 TAKEGUCHI N, ICHIMURA K, KOIKE M, MATSUI W, KASHIWAGURA T, et al.

INHIBITION OF THE MULTIDRUG EFFLUX PUMP IN ISOLATED HEPATOCYTE COUPLETS BY IMMUNOSUPPRESSANTS FK506 AND CYCLOSPORINE

TRANSPLANTATION. 1993 MAR; 55 (3): 646-650

555

1446 FABIAN MC, LAKEY JRT, RAJOTTE RV, KNETEMAN NM

THE EFFICACY AND TOXICITY OF RAPAMYCIN IN MURINE ISLET TRANSPLANTATION - IN-VITRO AND IN-VIVO STUDIES

TRANSPLANTATION. 1993 NOV; 56 (5): 1137-1142

556

1467 DUNCAN JI

DIFFERENTIAL INHIBITION OF CUTANEOUS T-CELL-MEDIATED REACTIONS AND EPIDERMAL-CELL PROLIFERATION BY CYCLOSPORINE-A, FK-506, AND RAPAMYCIN

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1994 JAN; 102 (1): 84-88

557

1488 HIGH KP, JOINER KA, HANDSCHUMACHER RE

ISOLATION, CDNA SEQUENCES, AND BIOCHEMICAL-CHARACTERIZATION OF THE MAJOR CYCLOSPORINE-BINDING PROTEINS OF TOXOPLASMA-GONDII

JOURNAL OF BIOLOGICAL CHEMISTRY. 1994 MAR 25; 269 (12): 9105-9112

558

1626 GORCZYNSKI RM

REGULATION OF IFN-GAMMA AND IL-10 SYNTHESIS IN-VIVO, AS WELL AS CONTINUOUS ANTIGEN EXPOSURE, IS ASSOCIATED WITH TOLERANCE TO MURINE SKIN ALLOGRAFTS

CELLULAR IMMUNOLOGY. 1995 FEB; 160 (2): 224-231

559

1663 THOMSON AW, LU L, SUBBOTIN VM, LI YP, QIAN SG, et al.

IN-VITRO PROPAGATION AND HOMING OF LIVER-DERIVED DENDRITIC CELL PROGENITORS TO LYMPHOID-TISSUES OF ALLOGENEIC RECIPIENTS - IMPLICATIONS FOR THE ESTABLISHMENT AND MAINTENANCE OF DONOR CELL CHIMERISM FOLLOWING LIVER-TRANSPLANTATION

TRANSPLANTATION. 1995 FEB 27; 59 (4): 544-551

560

1752 STARZL TE, DONNER A, ELIASZIW M, STITT L, MEIER P, et al.

RANDOMIZED TRIALOMANIA - THE MULTICENTER LIVER-TRANSPLANT TRIALS OF TACROLIMUS

LANCET. 1995 NOV 18; 346 (8986): 1346-1350

Date / Author / Journal

LCS

GCS

LCR

561

1908 GarciaMorales R, Esquenazi V, Zucker K, Gomez CI, Fuller L, et al.

An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry

TRANSPLANTATION. 1996 OCT 27; 62 (8): 1149-1160

562

2122 Paradis I

Bronchiolitis obliterans: Pathogenesis, prevention, and management

AMERICAN JOURNAL OF THE MEDICAL SCIENCES. 1998 MAR; 315 (3): 161-178

165

563

2368 Gorantla VS, Barker JH, Jones JW, Prabhune K, Maldonado C, et al.

Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies

MICROSURGERY. 2000; 20 (8): 420-429

564

2426 Morelli AE, O'Connell PJ, Khanna A, Logar AJ, Lu L, et al.

Preferential induction of Th1 responses by functionally mature hepatic (CD8 alpha(-) and CD8 alpha(+)) dendritic cells - Association with conversion from liver transplant tolerance to acute rejection

TRANSPLANTATION. 2000 JUN 27; 69 (12): 2647-2657

565

2776 Taylor AL, Gibbs P, Bradley JA

Acute graft versus host disease following liver transplantation: The enemy within

AMERICAN JOURNAL OF TRANSPLANTATION. 2004 APR; 4 (4): 466-474

566

221 MANDEL MA, ASOFSKY R

EFFECTS OF HETEROLOGOUS ANTI-THYMOCYTE SERA IN MICE .I. USE OF A GRAFT-VS-HOST ASSAY AS A MEASURE OF HOMOGRAFT REACTIVITY

JOURNAL OF IMMUNOLOGY. 1968; 100 (6): 1319-&

567

272 SELL S

ANTILYMPHOCYTIC ANTIBODY - EFFECTS IN EXPERIMENTAL ANIMALS AND PROBLEMS IN HUMAN USE

ANNALS OF INTERNAL MEDICINE. 1969; 71 (1): 177-&

156

568

681 MEYERS WC, HARRIS N, STEIN S, BROOKS M, JONES RS, et al.

ALIMENTARY-TRACT COMPLICATIONS AFTER RENAL-TRANSPLANTATION

ANNALS OF SURGERY. 1979; 190 (4): 535-542

569

1006 STARZL TE, TODO S, Tzakis AG, GORDON RD, MAKOWKA L, et al.

LIVER-TRANSPLANTATION - AN UNFINISHED PRODUCT

TRANSPLANTATION PROCEEDINGS. 1989 FEB; 21 (1): 2197-2197

570

1016 BIRD G, FRIEND P, DONALDSON P, OGRADY J, PORTMANN B, et al.

HYPERACUTE REJECTION IN LIVER-TRANSPLANTATION - A CASE-REPORT

TRANSPLANTATION PROCEEDINGS. 1989 AUG; 21 (4): 3742-3744

Date / Author / Journal

LCS

GCS

LCR

571

1701 KANAMARU A, TAKEMOTO Y, KAKISHITA E, DOHY H, KODERA Y, et al.

FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND/OR OTHER IMMUNOSUPPRESSANTS

BONE MARROW TRANSPLANTATION. 1995 JUN; 15 (6): 885-889

572

1957 Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, et al.

Positive and negative MHC class I recognition by rat NK cells

IMMUNOLOGICAL REVIEWS. 1997 FEB; 155: 91-104

573

2111 Bumgardner GL, Li JS, Heininger M, Ferguson RM, Orosz CG

In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model

TRANSPLANTATION. 1998 JAN 15; 65 (1): 47-52

574

2199 Ehl S, Aichele P, Ramseier H, Barchet W, Hombach J, et al.

Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection

NATURE MEDICINE. 1998 SEP; 4 (9): 1015-1019

575

2559 Wong SHY

Therapeutic drug monitoring for immunosuppressants

CLINICA CHIMICA ACTA. 2001 NOV; 313 (1-2): 241-253

576

2680 Creput C, Durrbach A, Samuel D, Eschwege P, Amor M, et al.

Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation

AMERICAN JOURNAL OF TRANSPLANTATION. 2003 MAR; 3 (3): 348-356

577

2847 Fung JJ, Kelly D, Kadry Z, Patel-Tom K, Eghtesad B

Immunosuppression in liver transplantation beyond calcineurin inhibitors

LIVER TRANSPLANTATION. 2005 MAR; 11 (3): 267-280

100

578

3036 Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, et al.

High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-Regulatory cells in liver transplant tolerance

TRANSPLANTATION. 2008 FEB 15; 85 (3): 369-377

579

109 GUNNELLS JC, STICKEL DL, ROBINSON RR

EPISODIC HYPERTENSION ASSOCIATED WITH POSITIVE RENIN ASSAYS AFTER RENAL TRANSPLANTATION

NEW ENGLAND JOURNAL OF MEDICINE. 1966; 274 (10): 543-&

580

400 MCPHAUL JJ, DIXON FJ, BRETTSCH.L, STARZL TE

IMMUNOFLUORESCENT EXAMINATION OF BIOPSIES FROM LONG-TERM RENAL ALLOGRAFTS

NEW ENGLAND JOURNAL OF MEDICINE. 1970; 282 (8): 412-&

Date / Author / Journal

LCS

GCS

LCR

581

689 NOVICK AC, MAGNUSSON M, BRAUN WE

MULTIPLE-ARTERY RENAL-TRANSPLANTATION - EMPHASIS ON EXTRACORPOREAL METHODS OF DONOR ARTERIAL RECONSTRUCTION

JOURNAL OF UROLOGY. 1979; 122 (6): 731-735

582

795 IWATSUKI S, SHAW BW, STARZL TE

CURRENT STATUS OF HEPATIC TRANSPLANTATION

SEMINARS IN LIVER DISEASE. 1983; 3 (3): 173-180

583

891 CONLEY SB, FLECHNER SM, ROSE G, VANBUREN CT, BREWER E, et al.

USE OF CYCLOSPORINE IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS

JOURNAL OF PEDIATRICS. 1985; 106 (1): 45-49

584

906 STARZL TE, IWATSUKI S, SHAW BW, GORDON RD, ESQUIVEL C, et al.

FACTORS IN THE DEVELOPMENT OF LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1985; 17: 107-119

585

1002 ROZA AM, PERLOFF LJ, NAJI A, GROSSMAN RA, BARKER CF

TRANSPLANTATION. 1989 FEB; 47 (2): 397-399

586

1239 MCCAULEY J, FUNG JJ, TODO S, JAIN A, DEBALLI P, et al.

CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3143-3145

587

1377 THOMSON AW, CARROLL PB, MCCAULEY J, WOO J, ABUELMAGD K, et al.

FK-506 - A NOVEL IMMUNOSUPPRESSANT FOR TREATMENT OF AUTOIMMUNE-DISEASE - RATIONALE AND PRELIMINARY CLINICAL-EXPERIENCE AT THE UNIVERSITY-OF- PITTSBURGH

SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 1993 APR; 14 (4): 323-344

588

1393 GIANELLO P, FISHBEIN JM, SACHS DH

TOLERANCE TO PRIMARILY VASCULARIZED ALLOGRAFTS IN MINIATURE SWINE

IMMUNOLOGICAL REVIEWS. 1993 JUN; 133: 19-44

589

1653 SHAPIRO R, JORDAN ML, SCANTLEBURY VP, VIVAS C, FUNG JJ, et al.

A PROSPECTIVE, RANDOMIZED TRIAL OF FK-506 PREDNISONE VS FK-506 AZATHIOPRINE/PREDNISONE IN RENAL-TRANSPLANT PATIENTS

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 814-817

590

1710 STEINMAN R, HOFFMAN L, POPE M

MATURATION AND MIGRATION OF CUTANEOUS DENDRITIC CELLS

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1995 JUL; 105 (1): S2-S7

Date / Author / Journal

LCS

GCS

LCR

591

1862 Mayumi H, Umesue M, Nomoto K

Cyclophosphamide-induced immunological tolerance: An overview

IMMUNOBIOLOGY. 1996 JUL; 195 (2): 129-139

592

1950 Tu YZ, Arima T, Flye MW

Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation

TRANSPLANTATION. 1997 JAN 27; 63 (2): 177-181

593

2753 Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, et al.

Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen- activated protein kinases and NF-kappa B

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2004 JAN 2; 313 (1): 148-155

594

429 TORISU M, YOKOYAMA T, AMEMIYA H, KOHLER PF, SCHROTER G, et al.

IMMUNOSUPPRESSION, LIVER INJURY, AND HEPATITIS IN RENAL, HEPATIC, AND CARDIAC HOMOGRAFT RECIPIENTS - WITH PARTICULAR REFERENCE TO AUSTRALIA ANTIGEN

ANNALS OF SURGERY. 1971; 174 (4): 620-&

595

679 GUICE K, RATTAZZI LC, MARCHIORO TL

COLON PERFORATION IN RENAL-TRANSPLANT PATIENTS

AMERICAN JOURNAL OF SURGERY. 1979; 138 (1): 43-48

596

747 STROM TB

THE IMPROVING UTILITY OF RENAL-TRANSPLANTATION IN THE MANAGEMENT OF END-STAGE RENAL-DISEASE

AMERICAN JOURNAL OF MEDICINE. 1982; 73 (1): 105-124

148

597

848 YATSCOFF RW, RUSH DN, JEFFERY JR

EFFECTS OF SAMPLE PREPARATION ON CONCENTRATIONS OF CYCLOSPORIN-A MEASURED IN PLASMA

CLINICAL CHEMISTRY. 1984; 30 (11): 1812-1814

598

913 MAKOWKA L, LOPATIN W, GILAS T, FALK J, PHILLIPS MJ, et al.

PREVENTION OF CYCLOSPORINE (CYA) NEPHROTOXICITY BY SYNTHETIC PROSTAGLANDINS

CLINICAL NEPHROLOGY. 1986; 25: S89-S94

599

1015 FRIEND PJ, HALE G, WALDMANN H, GORE S, THIRU S, et al.

CAMPATH-1M - PROPHYLACTIC USE AFTER KIDNEY-TRANSPLANTATION - A RANDOMIZED CONTROLLED CLINICAL-TRIAL

TRANSPLANTATION. 1989 AUG; 48 (2): 248-253

600

1028 MONAGHAN RL, TKACZ JS

BIOACTIVE MICROBIAL PRODUCTS - FOCUS UPON MECHANISM OF ACTION

ANNUAL REVIEW OF MICROBIOLOGY. 1990; 44: 271-301

260

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records